FLUOGUIDE A/S DK -1 Cash Flow Conversion Efficiency

Latest as of December 2025: -0.092x

FLUOGUIDE A/S DK -1 cash flow conversion efficiency. Based on the latest financial reports, FLUOGUIDE A/S DK -1 (96X) has a cash flow conversion efficiency ratio of -0.092x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-5.03 Million ≈ $-5.88 Million USD) by net assets (€54.53 Million ≈ $63.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of FLUOGUIDE A/S DK -1 (2021–2025)

Cash flow conversion efficiency of FLUOGUIDE A/S DK -1 from 2021 to 2025. This chart illustrates how FLUOGUIDE A/S DK -1's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 96X stock price for real-time trading data and today's change.

FLUOGUIDE A/S DK -1 Cash Flow Conversion Ratio Explained

FLUOGUIDE A/S DK -1 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

FLUOGUIDE A/S DK -1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of FLUOGUIDE A/S DK -1 ranked by their cash flow conversion efficiency. Also see 96X market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
TY Holdings Co Ltd
KO:363280
-0.031x
CONCORD ENVIRO SYSTEMS L
NSE:CEWATER
-0.071x
Kutahya Porselen Sanayi AS
IS:KUTPO
-0.056x
Grazziotin S.A
SA:CGRA3
0.028x
Univastu India Limited
NSE:UNIVASTU
-0.089x
Precision Optics Corporation, Inc. Common stock
NASDAQ:POCI
-0.032x
Townsquare Media Inc
NYSE:TSQ
-0.040x
Everbrite Technology Co Ltd
TWO:4523
-0.042x

Annual Cash Flow Conversion Efficiency for FLUOGUIDE A/S DK -1 (2021–2025)

The table below shows the annual cash flow conversion efficiency of FLUOGUIDE A/S DK -1 from 2021 to 2025. Review 96X financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €54.53 Million
≈ $63.75 Million
€-36.96 Million
≈ $-43.21 Million
-0.678x +46.37%
2024-12-31 €23.07 Million
≈ $26.97 Million
€-29.15 Million
≈ $-34.08 Million
-1.264x +49.46%
2023-12-31 €12.72 Million
≈ $14.87 Million
€-31.81 Million
≈ $-37.19 Million
-2.501x -112.36%
2022-12-31 €31.97 Million
≈ $37.37 Million
€-37.65 Million
≈ $-44.01 Million
-1.178x -202.57%
2021-12-31 €38.70 Million
≈ $45.25 Million
€-15.06 Million
≈ $-17.61 Million
-0.389x --

About FLUOGUIDE A/S DK -1

F:96X Germany Biotechnology
Market Cap
$50.27 Million
€43.00 Million EUR
Market Cap Rank
#21707 Global
#1931 in Germany
Share Price
€2.63
Change (1 day)
+1.15%
52-Week Range
€2.51 - €4.06
All Time High
€13.84
About

FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatmen… Read more